Neogen (NEOG) Insider Filing: RSU Vesting and Partial Sale by CFO
Rhea-AI Filing Summary
Neogen Corp (NEOG) Form 4 summary: Chief Financial Officer David H. Naemura reported vesting and settlement of 14,294 restricted stock units on 08/18/2025 at an indicated price of $5.43 per share, resulting in acquisition of 14,294 shares. The filing also shows a contemporaneous disposition of 5,947 shares at $5.43, leaving the reporting person with 69,781 shares after the transactions. The form was signed by an attorney-in-fact on 08/20/2025. This filing documents an insider equity vesting event and partial sale of shares.
Positive
- 14,294 RSUs vested and settled, converting compensation into common stock which aligns executive pay with shareholder interests
- Insider still holds 69,781 shares after transactions, maintaining ongoing ownership in the company
Negative
- Sale of 5,947 shares at $5.43 reduced the reporting person's holdings, representing a partial divestment
Insights
TL;DR: Routine officer vesting and partial sale; reflects compensation settlement, not an unusual market signal.
David Naemura's RSUs vested and were settled into 14,294 shares on 08/18/2025; a simultaneous sale of 5,947 shares at $5.43 per share reduced his post-transaction holdings to 69,781 shares. The transactions appear to be standard compensation-related activity (RSU vesting and partial disposition) rather than event-driven trading. No additional cash-only purchases or option exercises are reported.
TL;DR: Typical executive compensation settlement and partial sell-down; governance controls appear followed.
The filing specifies RSUs vested and were settled into an equivalent number of common shares on the same date, with the reporting person identified as CFO. The Form 4 is properly executed by an attorney-in-fact and discloses both acquisition (RSU settlement) and disposition amounts. There is no indication of rule 10b5-1 plan notation checked on the form, so these appear as routine post-vesting transactions disclosed under Section 16.